Association between colchicine resistance and vitamin D in familial Mediterranean fever

Figures & data

Table 1. Serum Ca, P, PTH and plasma vitamin D levels of the FMF patients and the control group.

	CR patients (mean ± SD)	Non-CR patients (mean ± SD)	p
Mean age (years)	31.45 ± 2.72	34.47 ± 2.11	>0.01
Disease duration (months)	147.83 ± 29.84	207.35 ± 22.67	>0.01
Mean colchicine dose (mg/day)	2.53 ± 0.09	1.57 ± 0.05	<0.01
Ca (mg/dL)	9.3 ± 0.4	9.4 ± 0.6	>0.01
P (mg/dL)	3.5 ± 0.3	3.8 ± 0.5	>0.01
PTH (pg/mL)	87 ± 32	45 ± 30	<0.01
Vitamin D (ng/mL)	9.39 ± 1.00	18.48 ± 1.09	<0.01

Table 2. Plasma 25-OHD levels in FMF patients with different MEFV gene mutations.

	Vitamin D levels (ng/mL)
M694V/M694V	10.2 ± 8.09
M694V/other	16.29 ± 8.24
Other/other	12.36 ± 5.44
Negative	14.05 ± 8.7